Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Radiopharm Theranostics, Ltd, explained in plain language.
This study tests a new imaging agent called RAD101 for PET scans in 30 adults with suspected recurrent brain metastases from solid tumors like lung or breast cancer. Participants receive one dose of RAD101 and undergo a PET scan, with results compared to standard MRI. The goal is…
Phase: PHASE2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Diagnosis
Last updated May 13, 2026 16:02 UTC